Scientific Sessions 2024  /  Obesity and Cardiovascular Outcomes: A Lancet Journal Session  /  The evolving therapeutic landscape in obesity and the effect on cardiovascular outcomes
Logo

American Heart Association

  2
  0

Final ID:

The evolving therapeutic landscape in obesity and the effect on cardiovascular outcomes

  • Kosiborod, Mikhail  ( ST LUKES HEALTH SYSTEM , Kansas City , Missouri , United States )
    • Author Disclosures:
    Mikhail Kosiborod: DO have relevant financial relationships ; Consultant:35Pharma, Imbria Pharmaceuticals:Active (exists now) ; Consultant:Esperion Therapeutics, Structure Therapeutics:Active (exists now) ; Consultant:Eli Lilly, scPharmaceuticals:Active (exists now) ; Consultant:Dexcom, Sanofi, Youngene Therapeutics:Active (exists now) ; Consultant:Cytokinetics, Regeneron:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer, Pharmacosmos:Active (exists now) ; Other (please indicate in the box next to the company name):AstraZeneca, Vifor Pharma - data analytic center fees:Active (exists now) ; Consultant:AstraZeneca, Pfizer, Vifor Pharma:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca, Pfizer:Active (exists now) ; Consultant:Arrowhead Pharmaceuticals:Active (exists now) ; Consultant:Applied Therapeutics:Active (exists now) ; Consultant:Amgen, NovoNordisk:Active (exists now) ; Consultant:Alnylam, Merck (Diabetes and Cardiovascular):Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Obesity and Cardiovascular Outcomes: A Lancet Journal Session

Saturday, 11/16/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Inequity and determinants of cardiovascular health in obesogenic environments

Lingvay Ildiko, Gulati Martha, Franks Paul

Looking towards the future: challenges for policy and practice

Sumithran Priya, Deanfield John

More abstracts from these authors:
Obesity Pharmacotherapy – where are we now?

Stanford Fatima, Kosiborod Mikhail

Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial

Kosiborod Mikhail

You have to be authorized to contact abstract author. Please, Login
Not Available